JUL 17·SEC EDGARLow
Flynn James E sold (to issuer) $2.1B of NUVL (indirect holdings)
Flynn James E sold (to issuer) 17,251,894 indirectly-held shares of Nuvalent, Inc. (NUVL) at $124.00 ($2.14B total) across 4 trades on 2026-07-15.
StockDelisted · Aug 2026NASDAQ · US · USDHealthcare · Biotechnology
$NUVL
Nuvalent, Inc.
Price · $NUVLvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $NUVL in the last 7 days.
Insider · 30dAll trades →
No SEC Form 4 filings for $NUVL in the last 30 days.
See all $NUVL insider activity →Top stories · $NUVLMore →
JUL 15·SEC EDGAR
Balcom Alexandra sold (to issuer) 55,450 shares of NUVL
Balcom Alexandra (Chief Financial Officer) sold (to issuer) 55,450 shares of Nuvalent, Inc. (NUVL) across 2 trades on 2026-07-15.
JUL 15·SEC EDGAR
Porter James Richard sold (to issuer) 161,375 shares of NUVL
Porter James Richard (President and CEO) sold (to issuer) 161,375 shares of Nuvalent, Inc. (NUVL) across 2 trades on 2026-07-15.
NUVL sentiment & insider activity
Recent NUVL coverage spans insider activity, mergers & acquisitions and financial news.
What's driving NUVL
Large insider sale to the issuer is a liquidity event and can signal reduced insider exposure, but it is not necessarily bearish without context on buyback mechanics or valuation.
This is an insider sale to the issuer (likely buyback participation or similar), but the filing provides no price, so near-term trading signal is limited.
This is an insider sale to the issuer with no disclosed price and no 10b5-1 plan stated, which can modestly affect sentiment but is not a fundamental catalyst.
This is a routine insider sale to the issuer (buyback participation style) with no disclosed price, so it is unlikely to change fundamentals but can slightly affect near-term sentiment.
NUVL is effectively removed from standalone trading as the acquisition closes, with value realized via the tender consideration.
alphai scores every news story that mentions NUVL with an AI model for sentiment and relevance, and aggregates insider trades from Nuvalent, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $NUVL
Score
Flynn James E sold (to issuer) $2.1B of NUVL (indirect holdings)
Flynn James E sold (to issuer) 17,251,894 indirectly-held shares of Nuvalent, Inc. (NUVL) at $124.00 ($2.14B total) across 4 trades on 2026-07-15.
2 min readBalcom Alexandra sold (to issuer) 55,450 shares of NUVL
Balcom Alexandra (Chief Financial Officer) sold (to issuer) 55,450 shares of Nuvalent, Inc. (NUVL) across 2 trades on 2026-07-15.
1 min readPorter James Richard sold (to issuer) 161,375 shares of NUVL
Porter James Richard (President and CEO) sold (to issuer) 161,375 shares of Nuvalent, Inc. (NUVL) across 2 trades on 2026-07-15.
2 min readWheeler Cameron sold (to issuer) 3,444 shares of NUVL
Wheeler Cameron sold (to issuer) 3,444 shares of Nuvalent, Inc. (NUVL) on 2026-07-15.
2 min read
GSK completes acquisition of Nuvalent, Inc
GSK said it has completed its acquisition of Nuvalent (NASDAQ: NUVL) via a tender offer. The deal adds three lung cancer assets, including zidesamtinib (NVL-520) and neladalkib (NVL-655) under FDA review, plus NVL-330 in phase I. Transaction value is about $10.6B (£8.0B), net investment about $9.4B (£7.1B).
4 min readNuvalent, Inc. (NUVL): Completion of Acquisition or Disposition of Assets
Nuvalent, Inc. (NUVL) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-3.2 3 d52896dex32.htm EX-3.2 EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BY-LAWS OF NUVALENT, INC. ARTICLE I OFFICES SECTION 1.1 REGISTERED OFFICE. The registered office shall be established and maintained at the office of Corporation Service Company, in the City of Wilmington, in
2 min readPorter James Richard sold $3.7M of NUVL
Porter James Richard (President and CEO) sold 30,000 shares of Nuvalent, Inc. (NUVL) at $123.72 ($3.71M total) on 2026-07-06 under a Rule 10b5-1 trading plan.
2 min readNoci Darlene sold $2.8M of NUVL
Noci Darlene (Chief Development Officer) sold 23,000 shares of Nuvalent, Inc. (NUVL) at $123.59 ($2.84M total) on 2026-07-01 under a Rule 10b5-1 trading plan.
2 min readNoci Darlene sold $679K of NUVL
Noci Darlene (Chief Development Officer) sold 5,500 shares of Nuvalent, Inc. (NUVL) at $123.51 ($0.68M total) on 2026-06-29 under a Rule 10b5-1 trading plan.
2 min read
Here Are Wednesday’s Best Wall Street Analyst Research Calls: Devon Energy, Flowserve, Klaviyo, Macerich, Merck, Nucor, Take-Two Interactive Software, Twilio, and More
Wall Street analyst calls for June 24, 2026 covered upgrades, downgrades, and initiations across sectors. Wells Fargo upgraded Invitation Homes to Overweight, lifting its target to $33. Citigroup raised Macerich to Buy ($28). KeyBanc increased Nucor to Overweight ($274). Downgrades included Flowserve to Hold ($70) at TD Cowen and Nuvalent to Market Perform ($124) from Bernstein.
4 min read